| Followers | 30 |
| Posts | 3322 |
| Boards Moderated | 0 |
| Alias Born | 08/21/2015 |
Wednesday, January 26, 2022 1:20:35 PM
“No such thing... this was an agreed upon termination...”
Doubt it. NP was going to sink with the ship until the very last minute and milk every dollar out of CYDY. He would never agree to step down.
We may never know, but I strongly suspect the new CoB, Tanya, started orchestrating NP’s removal back in December when it was clear that Samsung and Amarex weren’t going to be paid, but the Proactiv bill would be. IMO, she convinced SK to step down first (using the SEC/DOJ investigation as leverage), which gave her the votes to oust NP. This has likely been the plan since she was identified as a candidate for the BOD. Paulson cannot let CYDY fail and they likely recommended her to NP and with her impressive background. NP agreed to his own fate at CYDY. She has executed the strategy fairly well so far and it’ll be interesting how she moves forward from this point.
Doubt it. NP was going to sink with the ship until the very last minute and milk every dollar out of CYDY. He would never agree to step down.
We may never know, but I strongly suspect the new CoB, Tanya, started orchestrating NP’s removal back in December when it was clear that Samsung and Amarex weren’t going to be paid, but the Proactiv bill would be. IMO, she convinced SK to step down first (using the SEC/DOJ investigation as leverage), which gave her the votes to oust NP. This has likely been the plan since she was identified as a candidate for the BOD. Paulson cannot let CYDY fail and they likely recommended her to NP and with her impressive background. NP agreed to his own fate at CYDY. She has executed the strategy fairly well so far and it’ll be interesting how she moves forward from this point.
Recent CYDY News
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 05/21/2026 04:15:12 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/20/2026 09:08:39 PM
- CytoDyn to Present at the LD Micro Invitational XVI • GlobeNewswire Inc. • 05/15/2026 12:30:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/30/2026 08:32:50 PM
- CytoDyn Announces First Patient Dosed in Expanded Access Program for Leronlimab in Triple-Negative Breast Cancer • GlobeNewswire Inc. • 04/27/2026 12:30:00 PM
- CytoDyn to Host Investor Webcast • GlobeNewswire Inc. • 04/23/2026 12:30:00 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 04/22/2026 09:21:50 PM
- CytoDyn Presents New Leronlimab Data in Metastatic Colorectal Cancer at AACR Annual Meeting 2026 • GlobeNewswire Inc. • 04/22/2026 12:30:00 PM
- CytoDyn Completes Enrollment in Phase 2 Metastatic Colorectal Cancer Study • GlobeNewswire Inc. • 04/21/2026 08:10:00 PM
- CytoDyn Presents New Leronlimab Data in Metastatic Triple-Negative Breast Cancer at AACR Annual Meeting 2026 • GlobeNewswire Inc. • 04/20/2026 12:30:00 PM
- CytoDyn to Present at the AACR Annual Meeting 2026 • GlobeNewswire Inc. • 04/14/2026 12:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 04/08/2026 09:15:18 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 04/08/2026 12:30:28 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/25/2026 09:16:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:24:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:23:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:22:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:21:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:20:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:20:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/24/2026 09:15:24 PM
- CytoDyn Presents at AACR Special Conference in Cancer Research: Brain Cancer • GlobeNewswire Inc. • 03/24/2026 12:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/09/2026 09:15:18 PM
